Understanding Penicillin Allergy, Cross-reactivity, and Antibiotic Selection in the Preoperative Setting.

J Am Acad Orthop Surg · Jan 01 2022 · Review

Sarfani S, Stone CA, Murphy GA, Richardson DR

From the University of Tennessee- Campbell Clinic Orthopaedics, Memphis, TN (Sarfani, TN (Stone)

General Orthopaedics

SUMMARY — THE REDUCTIONMost reported penicillin allergies are not true allergies, and using non-beta-lactam alternatives increases surgical site infection risk, prompting new preoperative antibiotic selection guidelines and a risk stratification tool.
Abstract, as published

Penicillin allergies are reported by 8% to 15% of the US population, but up to 95% of these allergies do not correspond to a true allergy when tested. Recent studies have demonstrated that having a penicillin allergy label (PAL) results in a 50% increased odds of surgical site infection among patients reporting a penicillin allergy entirely attributable to the use of a beta-lactam alternative antibiotic (primarily clindamycin or vancomycin). This study provides a review of the prevalence of PAL, the cross-reactivity with cefazolin, immunogenic components of cefazolin and penicillin, and current guidelines for preoperative antibiotic selection in patients with PALs. On understanding these principles, a new set of guidelines and a risk stratification tool are proposed for assessing allergies and determining appropriate antibiotic choice, dosage, and timing in the orthopaedic preoperative setting.

Featured in the 2026-08-21 issue.

← Experts Achieve Consensus on a Majority of Statements Regardi…Bone Marrow Edema: Overview of Etiology and Treatment Strateg… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.